Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

1
Player Avatar TMFBiologyFool (98.28) Submitted: 11/28/2011 12:47:55 PM : Outperform Start Price: $27.35 VRTX Score: +120.45

Seems too beaten down at these prices. See this article I wrote:7 Black Friday Biotech Bargainshttp://www.fool.com/investing/high-growth/2011/11/25/7-black-friday-biotech-bargains.aspx

Featured Broker Partners


Advertisement